Dr. Agarwal's Eye Hospital Limited

Rachunek Zysków i Strat





Przychody TTM (mln): 3 586
EBIT TTM (mln): 787
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Rok finansowy 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025
Przychód (mln) 132 402 728 880 1,028 1,035 1,085 1,127 1,182 1,366 1,485 1,533 1,694 1,752 1,396 2,010 2,672 3,193 3,972
Przychód Δ r/r 0.0% 204.9% 81.1% 20.9% 16.8% 0.7% 4.8% 3.8% 4.9% 15.6% 8.8% 3.2% 10.5% 3.5% -20.4% 44.0% 33.0% 19.5% 24.4%
Marża brutto 48.6% 100.0% 78.8% 77.7% 56.4% 55.6% 72.7% 73.7% 76.0% 86.8% 76.4% 78.1% 77.8% 77.2% 76.7% 76.8% 77.2% 34.4% 34.4%
EBIT (mln) -4 22 83 56 88 86 80 72 77 74 148 146 191 267 123 386 562 644 790
EBIT Δ r/r 0.0% -695.7% 275.2% -32.8% 57.1% -1.8% -7.4% -10.1% 7.8% -4.5% 100.4% -1.1% 30.1% 40.2% -54.1% 214.6% 45.8% 14.6% 22.7%
EBIT (%) -2.8% 5.5% 11.4% 6.3% 8.5% 8.3% 7.4% 6.4% 6.5% 5.4% 10.0% 9.6% 11.2% 15.2% 8.8% 19.2% 21.0% 20.2% 19.9%
Koszty finansowe (mln) 1 17 39 0 40 44 35 35 22 37 33 26 23 74 61 61 69 72 134
EBITDA (mln) 27 55 138 120 151 143 133 132 139 201 240 257 306 483 298 586 767 911 1,236
EBITDA(%) 20.2% 13.7% 19.0% 13.7% 14.7% 13.8% 12.3% 11.7% 11.8% 14.7% 16.2% 16.8% 18.1% 27.5% 21.4% 29.2% 28.7% 28.5% 31.1%
Podatek (mln) 3 4 4 5 16 13 13 13 -3 -5 36 66 55 63 72 82 125 159 160
Zysk Netto (mln) 6 2 2 5 20 16 31 24 57 0 73 68 119 137 -14 241 369 464 546
Zysk netto Δ r/r 0.0% -73.3% 31.1% 158.9% 291.0% -22.0% 96.4% -22.6% 134.4% -99.4% 19895.4% -7.7% 75.9% 14.8% -110.5% -1775.2% 53.2% 25.6% 17.9%
Zysk netto (%) 4.4% 0.4% 0.3% 0.6% 2.0% 1.5% 2.9% 2.2% 4.8% 0.0% 4.9% 4.4% 7.0% 7.8% -1.0% 12.0% 13.8% 14.5% 13.8%
EPS 1.78 0.34 0.45 1.16 4.55 3.55 6.98 5.25 12.12 0.08 15.61 14.42 25.35 29.11 -3.06 51.29 78.55 98.64 116.28
EPS (rozwodnione) 1.78 0.34 0.45 1.16 4.55 3.55 6.98 5.25 12.12 0.08 15.61 14.42 25.35 29.11 -3.06 51.29 78.55 98.64 116.28
Ilośc akcji (mln) 3 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 5 5
Ważona ilośc akcji (mln) 4 4 4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 5 5
Waluta INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR